SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-115681
Filing Date
2021-09-15
Accepted
2021-09-15 07:19:21
Documents
34
Period of Report
2021-09-15
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2127424d1_8k.htm   iXBRL 8-K 32620
2 EXHIBIT 99.1 tm2127424d1_ex99-1.htm EX-99.1 27068
3 EXHIBIT 99.2 tm2127424d1_ex99-2.htm EX-99.2 16539
4 EXHIBIT 99.3 tm2127424d1_ex99-3.htm EX-99.3 7483
5 EXHIBIT 99.4 tm2127424d1_ex99-4.htm EX-99.4 19232
9 GRAPHIC tm2127424d1_ex99-1img001.jpg GRAPHIC 7928
10 GRAPHIC tm2127424d1_ex99-2img001.jpg GRAPHIC 80599
11 GRAPHIC tm2127424d1_ex99-2img002.jpg GRAPHIC 83311
12 GRAPHIC tm2127424d1_ex99-2img003.jpg GRAPHIC 70768
13 GRAPHIC tm2127424d1_ex99-2img004.jpg GRAPHIC 45721
14 GRAPHIC tm2127424d1_ex99-2img005.jpg GRAPHIC 58374
15 GRAPHIC tm2127424d1_ex99-2img006.jpg GRAPHIC 45147
16 GRAPHIC tm2127424d1_ex99-3img001.jpg GRAPHIC 9672
17 GRAPHIC tm2127424d1_ex99-4img001.jpg GRAPHIC 68383
18 GRAPHIC tm2127424d1_ex99-4img002.jpg GRAPHIC 184874
19 GRAPHIC tm2127424d1_ex99-4img003.jpg GRAPHIC 208461
20 GRAPHIC tm2127424d1_ex99-4img004.jpg GRAPHIC 183349
21 GRAPHIC tm2127424d1_ex99-4img006.jpg GRAPHIC 72709
22 GRAPHIC tm2127424d1_ex99-4img007.jpg GRAPHIC 203057
23 GRAPHIC tm2127424d1_ex99-4img008.jpg GRAPHIC 81537
24 GRAPHIC tm2127424d1_ex99-4img009.jpg GRAPHIC 58528
25 GRAPHIC tm2127424d1_ex99-4img010.jpg GRAPHIC 129056
26 GRAPHIC tm2127424d1_ex99-4img011.jpg GRAPHIC 168602
  Complete submission text file 0001104659-21-115681.txt   2729056

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tbph-20210915.xsd EX-101.SCH 3194
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20210915_lab.xml EX-101.LAB 34593
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20210915_pre.xml EX-101.PRE 22716
27 EXTRACTED XBRL INSTANCE DOCUMENT tm2127424d1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 211254236
SIC: 2834 Pharmaceutical Preparations